The PennZone

  • Home
  • Business
  • Health
  • Construction
  • Technology
  • Entertainment
  • Travel
  • Music
  • Real Estate

ExpressCells to Present in BIO Start-Up Stadium Next Week
The PennZone/10070540

Trending...
  • New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
  • Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
  • Bent Danholm Named "Top Luxury Real Estate Leader" in Modern Luxury Miami
Company is one of 30 selected for prestigious competition. During BIO Digital Week, attendees can watch timely, on-demand pitches and meet with ExpressCells via BIO's One-on-One Partnering.

PHILADELPHIA - PennZone -- ExpressCells, Inc. (ExpressCells), a privately-owned genetic engineering company that creates knock-in cell lines for drug discovery, will be one of the finalists presenting in the Start-Up Stadium during BIO Digital Week.

"We are honored to be selected by the judges as one of the finalists for Start-Up Stadium. We hope that all BIO Digital Week attendees view our presentation, which will be available on demand via the meeting platform."

Start-Up Stadium provides an exciting and interactive experience where key stakeholders of the early-stage life science community, investors, and strategic partners provide feedback and judge 6 minute pitches presented by start-up biotech companies. During BIO Digital Week, attendees can watch ExpressCells' pitch on-demand and meet with the company via BIO's One-on-One Partnering.

More on The PennZone
  • Technology Leader and Army Veteran Releases Memoir on Late Autism Diagnosis
  • Training Lofts Launches $1,099 Unlimited Training Membership Featuring Semi-Private Coaching, Nutrition Support, and Recovery Services
  • God's Meal Barrel Announces Participation in Give Local York
  • American Properties Realty, Inc. Leadership Attends NAHB International Builders' Show in Florida
  • $317M Revenue and a Clear Path to $1B: $IQST is Positioned for a Major Profitability Inflection

"ExpressCells is excited to be part of BIO Digital Week," Mr. Handel continued. "We hope to gain valuable feedback and to meet with both potential customers and potential investors.

About ExpressCells

ExpressCells is a private biotechnology company based in Philadelphia, PA. Its propriety genome editing technology, in combination with CRISPR/Cas9, creates advanced, knock-in cell line up to 75% faster than older processes. This technology allows ExpressCells to insert up to three genes into the same cell line.

ExpressCells' first knock-in cell lines code for bioluminescent and fluorescent proteins. These allow scientists to more see the results of their experiments in real time. ExpressCells sells both custom cell lines—each designed to meet the specific requirements of an individual scientist—and catalog cell lines. For more information, visit www.xpresscells.com.

Contact
Matthew Handel
***@xpresscells.com
+1 (484) 483-6759


Source: ExpressCells, Inc.

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • $6 Million Funding Secured as Retail Expansion, Operational Streamlining, and Asset-Light Strategy Position the Company for Accelerated Growth $SOWG
  • The "Unsexy" Business Quietly Creating 130+ New Entrepreneurs Across America — From Alaska to Puerto Rico
  • Veteran Launches GTG Energy: Nicotine-Free Pouch as Americans Rethink Addiction, Focus, and What Fuels Performance
  • RecallSentry™ App Launch — Your Home Safety Hub — Free on iOS & Android
  • Award-Winning Director Crystal J. Huang's Under-$50K Film "The Ritual House" Wins Best Horror Feature at Golden State Film Festival
  • Grads aren't getting hired — here's what we're doing about it
  • L-Tron Returns from a Successful PACK EXPO East Conference
  • K2 Integrity Enhances Technology Capabilities Through Acquisition of Leviathan Security Group
  • #WeAreGreekWarriors Comes to Detroit in Celebration of Women's History Month
  • JKS Financial Marks Five-Year Partnership with University of Pittsburgh Basketball, United Way
  • Buildout Launches CRM, Completing the Industry's First AI-Powered End-to-End Deal Engine for CRE
  • Energywise Solutions and Pickleball Pros Partner to Bring More Energy and Visibility to Pickleball Clubs
  • The Franchise King® Releases Free Guide for Nervous Buyers
  • Kanguro Insurance Taps Paylode to Launch Best-in-Class Pet and Renters Insurance Rewards Experience
  • CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs
  • NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
  • Revenue Optics Launches Talent Infrastructure Platform for SaaS Revenue Hiring and Appoints Sabz Kaur to Lead Growth
  • Building a Multi-Domain Autonomous Systems Platform at the Intersection of AI, Defense and Infrastructure: VisionWave Holdings (N A S D A Q: VWAV)
  • Bent Danholm Named "Top Luxury Real Estate Leader" in Modern Luxury Miami
  • Author Ken Mora to Celebrate New Caravaggio Book Debut with Special Event at Palazzo Venezia Naples

Popular on PennZone

  • Cold. Clean. Anywhere. Meet FrostSkin
  • Ice Melts. Infrastructure Fails. What Happens to Clean Water?
  • The Legal AI Showdown: Westlaw, Lexis, ChatGPT… or EvenSteven?
  • Apostle Margelee Hylton Announces the Release of Third Day Prayer
  • When Representation No Longer Reflects the District — Why I'm Voting for Pete Verbica
  • Kilmaine Saints to Anchor St. Patrick's Day Weekend with Live Album Recording at XL Live
  • Vines of Napa Launches Partnership Program to Bolster Local Tourism and Economic Growth
  • Beethoven: Music of Revolution and Triumph - Eroica
  • Don't Get Burned by High Heater Prices in Philly This Winter!
  • Diversified Roofing Solutions Strengthens Industry Leadership With Expanded Roofing Services Across South Florida

Similar on PennZone

  • NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
  • Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
  • $167 Billion Pharma R&D Market Largely Untapped by AI Creates Major Growth Runway for KALA Bios Data-Sovereign AI Strategy: N A S D A Q: KALA
  • National Expansion Ignited Across Amazon $AMZN, Chewy $CHWY & Walmart $WMT: NDT Pharmaceuticals, Inc. (Stock Symbol: NDTP) $NDTP
  • Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
  • Postmortem Pathology Expands Independent Autopsy Services in Kansas City
  • ClearSight Therapeutics Signs LOI with Covalent Medical for $60M Multi-Channel OTC Eye Care Partnership
  • Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief
  • FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
  • Parkway Prosthodontics Achieves Breakthrough Full-Arch Reconstruction Case
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us